PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression

By Šmahel Michal  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1331-1331

MDPI

Access to resources Recommend Favorite

Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types

By Scognamiglio Giosuè   De Chiara Anna   Di Bonito Maurizio   Tatangelo Fabiana   Losito Nunzia Simona   Anniciello Annamaria   De Cecio Rossella   D’Alterio Crescenzo   Scala Stefania   Cantile Monica   Botti Gerardo  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 790-790

MDPI

Access to resources Recommend Favorite

Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice

By Rom-Jurek Eva-Maria   Kirchhammer Nicole   Ugocsai Peter   Ortmann Olaf   Wege Anja K.   Brockhoff Gero  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 563-563

MDPI

Access to resources Recommend Favorite

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

By Botti Gerardo   Collina Francesca   Scognamiglio Giosuè   Rao Federica   Peluso Valentina   De Cecio Rossella   Piezzo Michela   Landi Gabriella   De Laurentiis Michelino   Cantile Monica   Di Bonito Maurizio  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 459-459

MDPI

Access to resources Recommend Favorite

PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays

By Botti Gerardo   Scognamiglio Giosuè   Cantile Monica  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 1046-1046

MDPI

Access to resources Recommend Favorite